881 related articles for article (PubMed ID: 1304349)
21. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
23. Crystal structure of the complex of human alpha-thrombin and nonhydrolyzable bifunctional inhibitors, hirutonin-2 and hirutonin-6.
Zdanov A; Wu S; DiMaio J; Konishi Y; Li Y; Wu X; Edwards BF; Martin PD; Cygler M
Proteins; 1993 Nov; 17(3):252-65. PubMed ID: 8272424
[TBL] [Abstract][Full Text] [Related]
24. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
Mosesson MW; Hernandez I; Siebenlist KR
Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
[TBL] [Abstract][Full Text] [Related]
25. The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution.
Martin PD; Robertson W; Turk D; Huber R; Bode W; Edwards BF
J Biol Chem; 1992 Apr; 267(11):7911-20. PubMed ID: 1560020
[TBL] [Abstract][Full Text] [Related]
26. X-ray analyses of aspartic proteinases. V. Structure and refinement at 2.0 A resolution of the aspartic proteinase from Mucor pusillus.
Newman M; Watson F; Roychowdhury P; Jones H; Badasso M; Cleasby A; Wood SP; Tickle IJ; Blundell TL
J Mol Biol; 1993 Mar; 230(1):260-83. PubMed ID: 8450540
[TBL] [Abstract][Full Text] [Related]
27. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
Maurer MC; Trumbo TA; Isetti G; Turner BT
Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
[TBL] [Abstract][Full Text] [Related]
28. Allosteric changes in solvent accessibility observed in thrombin upon active site occupation.
Croy CH; Koeppe JR; Bergqvist S; Komives EA
Biochemistry; 2004 May; 43(18):5246-55. PubMed ID: 15122890
[TBL] [Abstract][Full Text] [Related]
29. Structure of human des(1-45) factor Xa at 2.2 A resolution.
Padmanabhan K; Padmanabhan KP; Tulinsky A; Park CH; Bode W; Huber R; Blankenship DT; Cardin AD; Kisiel W
J Mol Biol; 1993 Aug; 232(3):947-66. PubMed ID: 8355279
[TBL] [Abstract][Full Text] [Related]
30. Thrombomodulin Binding Selects the Catalytically Active Form of Thrombin.
Handley LD; Treuheit NA; Venkatesh VJ; Komives EA
Biochemistry; 2015 Nov; 54(43):6650-8. PubMed ID: 26468766
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions.
Church FC; Pratt CW; Noyes CM; Kalayanamit T; Sherrill GB; Tobin RB; Meade JB
J Biol Chem; 1989 Nov; 264(31):18419-25. PubMed ID: 2509458
[TBL] [Abstract][Full Text] [Related]
32. Refined 1.8 A X-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish Astacus astacus L. Structure determination, refinement, molecular structure and comparison with thermolysin.
Gomis-Rüth FX; Stöcker W; Huber R; Zwilling R; Bode W
J Mol Biol; 1993 Feb; 229(4):945-68. PubMed ID: 8445658
[TBL] [Abstract][Full Text] [Related]
33. The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
Wu TP; Yee V; Tulinsky A; Chrusciel RA; Nakanishi H; Shen R; Priebe C; Kahn M
Protein Eng; 1993 Jul; 6(5):471-8. PubMed ID: 8415574
[TBL] [Abstract][Full Text] [Related]
34. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
[TBL] [Abstract][Full Text] [Related]
35. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD
Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148
[TBL] [Abstract][Full Text] [Related]
37. Crystallographic structure of a peptidyl keto acid inhibitor and human alpha-thrombin.
Håkansson K; Tulinsky A; Abelman MM; Miller TA; Vlasuk GP; Bergum PW; Lim-Wilby MS; Brunck TK
Bioorg Med Chem; 1995 Aug; 3(8):1009-17. PubMed ID: 7582975
[TBL] [Abstract][Full Text] [Related]
38. Thrombin specificity.
Guillin MC; Bezeaud A; Bouton MC; Jandrot-Perrus M
Thromb Haemost; 1995 Jul; 74(1):129-33. PubMed ID: 8578445
[TBL] [Abstract][Full Text] [Related]
39. Crystallographic refinement and structure of ribulose-1,5-bisphosphate carboxylase from Rhodospirillum rubrum at 1.7 A resolution.
Schneider G; Lindqvist Y; Lundqvist T
J Mol Biol; 1990 Feb; 211(4):989-1008. PubMed ID: 2107319
[TBL] [Abstract][Full Text] [Related]
40. X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.
Brandstetter H; Bauer M; Huber R; Lollar P; Bode W
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9796-800. PubMed ID: 7568220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
